
Preclinical Scientist with 10+ years of R&D experience spanning pharmacology, PK/PD assay development, in vivo models, biomarker strategy, functional immunology, and CMC-related process development. Demonstrated success designing IND-enabling plans, leading cross-functional execution, developing study protocols, and managing CRO/CDMO partners to advance therapeutics from concept to IND. Also contribute to fundraising efforts—supporting pre-seed and seed rounds through scientific communication, investor engagement, and data-driven program positioning. Recognized for strong communication skills, effective leadership of scientists and external partners, and contributions to intellectual property, including assay development, nanoparticle characterization, and therapeutic design.